欧林生物:公司被诉1920万元

Core Viewpoint - The company has received a lawsuit notification from the Chengdu Intermediate People's Court, involving a claim of 19.2 million yuan, which includes 16 million yuan in product commissions and 3.2 million yuan in penalties [1] Group 1 - The company does not recognize the claims made by the plaintiff and will actively respond to the lawsuit [1] - The lawsuit is not expected to have a significant adverse impact on the company's operating revenue, production, or market sales of existing products [1]

Chengdu Olymvax Biopharmaceuticals -欧林生物:公司被诉1920万元 - Reportify